These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 29528010

  • 1. De Novo Thrombotic Microangiopathy in Renal Transplant Patients.
    Özdemir BH, Ok Atılgan A, Yılmaz Akçay E, Özdemir G, Ayvazoğlu Soy E, Akdur A, Haberal M.
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):131-135. PubMed ID: 29528010
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
    Tasaki M, Saito K, Nakagawa Y, Imai N, Ito Y, Yoshida Y, Ikeda M, Ishikawa S, Narita I, Takahashi K, Tomita Y.
    Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
    [Abstract] [Full Text] [Related]

  • 3. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J, Cho YM, Yang WS, Park TJ, Chang JW, Park SK.
    Clin Transplant; 2007 Dec; 21(2):159-65. PubMed ID: 17425739
    [Abstract] [Full Text] [Related]

  • 4. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.
    Satoskar AA, Pelletier R, Adams P, Nadasdy GM, Brodsky S, Pesavento T, Henry M, Nadasdy T.
    Am J Transplant; 2010 Aug; 10(8):1804-11. PubMed ID: 20659088
    [Abstract] [Full Text] [Related]

  • 5. The impact of C4d staining as a humoral injury marker.
    Kara M, Demir F, Ata P, Ozel L, Gumrukcu G, Unal E, Canbakan M, Gucun M, Esadoglu V, Ozdemir E, Cemel H, Titiz MI.
    Transplant Proc; 2012 Aug; 44(6):1694-6. PubMed ID: 22841245
    [Abstract] [Full Text] [Related]

  • 6. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.
    Meehan SM, Kremer J, Ali FN, Curley J, Marino S, Chang A, Kadambi PV.
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):395-403. PubMed ID: 20966124
    [Abstract] [Full Text] [Related]

  • 7. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T.
    Clin Transplant; 2008 Feb; 22(1):61-7. PubMed ID: 18217907
    [Abstract] [Full Text] [Related]

  • 8. Combination of Glomerular C4d and Morphologic Glomerular Lesions as a Possible Indicator in the Diagnosis of Acute or Chronic Active Antibody-Mediated Rejection.
    Lee YJ, Lee JH, Jung CW, Gwon JG, Ko SY, Lee J, Jo SK, Cho WY, Kim MG.
    Transplant Proc; 2019 Oct; 51(8):2660-2666. PubMed ID: 31445765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Living-Donor Kidney Transplant-Associated Thrombotic Microangiopathy Successfully Treated With Thymoglobulin: A Case Report.
    Akl A, Alobaidi S, Aboalsamh G.
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):175-177. PubMed ID: 30777549
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glomerular C4d deposits can mark structural capillary wall remodelling in thrombotic microangiopathy and transplant glomerulopathy: C4d beyond active antibody-mediated injury: a retrospective study.
    Gasim AH, Chua JS, Wolterbeek R, Schmitz J, Weimer E, Singh HK, Nickeleit V.
    Transpl Int; 2017 May; 30(5):519-532. PubMed ID: 28207978
    [Abstract] [Full Text] [Related]

  • 16. Thrombotic microangiopathy in the early post-renal transplant period.
    Ardalan MR, Shoja MM, Tubbs RS, Etemadi J, Esmaili H, Khosroshahi HT.
    Ren Fail; 2008 May; 30(2):199-203. PubMed ID: 18300121
    [Abstract] [Full Text] [Related]

  • 17. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
    Schwarz C, Regele H, Huttary N, Wahrmann M, Exner M, Nagy-Bojarsky K, Kletzmayr J, Hörl WH, Böhmig GA.
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.